INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 59 filers reported holding INSTIL BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $18,436 | +4.8% | 3,809 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $17,598 | -57.0% | 3,809 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $40,947 | -84.2% | 3,809 | -74.8% | 0.00% | -75.0% |
Q4 2021 | $258,737 | +129.4% | 15,122 | +139.7% | 0.00% | +100.0% |
Q3 2021 | $112,791 | -9.1% | 6,310 | -1.8% | 0.00% | 0.0% |
Q2 2021 | $124,112 | – | 6,424 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |